Lijun Sun
Geen lopende functies
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Hong Jen Chang | M | 68 | 5 jaar | |
Lan Hu | F | 53 | 5 jaar | |
Yi Fan Chen | M | 44 | 4 jaar | |
Ben Xiao | M | 42 | 2 jaar | |
De Qian Wang | M | 73 | 2 jaar | |
Chilton Varner | F | 81 |
Emory University
| 29 jaar |
Thomas J. Lawley | M | 77 |
Emory University
| 28 jaar |
Wing Yat Lui | M | 35 | 5 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Chen Schor | M | 51 |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | 2 jaar |
Safi R. Bahcall | M | 55 |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | 14 jaar |
George Farmer | M | - |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | - |
Steven B. Bernitz | M | 78 |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | 1 jaar |
Anne Michelle Whitaker | F | 56 |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | 1 jaar |
Keith Gollust | M | 78 |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | 14 jaar |
William Reardon | M | 78 |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | 12 jaar |
Lan Bo Chen | M | 80 |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | 11 jaar |
Keith S. Ehrlich | M | 73 |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | 10 jaar |
Marc R. Schneebaum | M | 69 |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | 2 jaar |
Christine Redmond | F | - |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | - |
Eric W. Jacobson | M | 66 |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | 4 jaar |
Philip Pallone | M | - |
Georgetown University
| 7 jaar |
Edwin Poston | M | 57 |
Emory University
| 4 jaar |
Dvorit Samid | M | - |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | - |
Kane Brenan | M | - |
Georgetown University
| 4 jaar |
Jon S. Bouker | M | - |
Georgetown University
| 4 jaar |
Peter D. Eberhart | M | - |
Emory University
| 3 jaar |
Italo Andres Zanzi | M | 50 |
Emory University
| 3 jaar |
Donald William Kufe | M | 79 |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | 6 jaar |
Martin J. Waters | M | - |
Georgetown University
| 7 jaar |
Robert Wilson | M | 83 |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | 13 jaar |
Dan Kamensky | M | - |
Georgetown University
| 7 jaar |
Daniel O’Shea | M | - |
Georgetown University
| 18 jaar |
Alan C. Rigby | M | - |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | - |
Nils Janson | M | - |
Georgetown University
| 5 jaar |
Paul Friedman | M | 81 |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | 2 jaar |
Bruce Kovner | M | 79 |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | 14 jaar |
Constantine S. Potamianos | M | 58 |
Georgetown University
| 5 jaar |
Valla Vakili | M | - |
Georgetown University
| 4 jaar |
Ambrosio P. Rufino | M | - |
Georgetown University
| 2 jaar |
Adam J. Wiensch | M | - |
Georgetown University
| 3 jaar |
Anjali Raghani Johannessen | F | 48 |
Georgetown University
| 4 jaar |
Steve Gillin | M | - |
Georgetown University
| 4 jaar |
Suzanne L. Rubin | F | - |
Georgetown University
| 4 jaar |
F. Matthew Embrescia | M | - |
Georgetown University
| 4 jaar |
David Lu | M | - |
Georgetown University
| 4 jaar |
Saifi Sharif Mohdi | M | - |
Georgetown University
| 3 jaar |
Steve O'Gorman | M | - |
Georgetown University
| 3 jaar |
John Bowman | M | 54 |
Georgetown University
| 4 jaar |
Steve Sweeney | M | - |
Georgetown University
| 4 jaar |
Dan Brennan | M | - |
Georgetown University
| 4 jaar |
Matthew James | M | - |
Georgetown University
| 4 jaar |
Martin Walsh | M | - |
Georgetown University
| 4 jaar |
John M. Burke | M | - |
Georgetown University
| 3 jaar |
Darren C. Skinner | M | - |
Georgetown University
| 3 jaar |
Kang Bin Zheng | M | 60 |
Georgetown University
| 3 jaar |
Alec Scheiner | M | 54 |
Georgetown University
| 4 jaar |
Ned Segal | M | 49 |
Georgetown University
| 4 jaar |
Timothy Enneking | M | - |
Georgetown University
| 2 jaar |
Boguslaw Nadolnik | M | - |
Georgetown University
| 2 jaar |
Baihua Gong | M | 61 |
Georgetown University
| 3 jaar |
Raymond J. Peloso | M | - |
Georgetown University
| 2 jaar |
Brett Harold Krause | M | 55 |
Georgetown University
| 4 jaar |
Felice C. Wagner | F | - |
Georgetown University
| 3 jaar |
Deanne M. Ottaviano | F | - |
Georgetown University
| 3 jaar |
Matt Joseph Schmidt | M | 50 |
Georgetown University
| 4 jaar |
Shelby Tucker | M | - |
Georgetown University
| 2 jaar |
Anne Nisenson Mathias | F | - |
Georgetown University
| 2 jaar |
John M. Williams | M | - |
Georgetown University
| 3 jaar |
Gerard Daniel O'Brien | M | 62 |
Georgetown University
| 2 jaar |
Timothy P. Ramsey | M | - |
Georgetown University
| 4 jaar |
Tim Nollen | M | - |
Georgetown University
| 4 jaar |
James David Bailey | M | - |
Georgetown University
| 4 jaar |
Richard Crable | M | - |
Georgetown University
| 2 jaar |
Katsuya Natori | M | 65 |
Georgetown University
| 2 jaar |
Meredith Lee McDaniel | F | - |
Georgetown University
| 4 jaar |
Todd William Solomon | M | 54 |
Georgetown University
| 4 jaar |
Andy Weissman | M | - |
Georgetown University
| 3 jaar |
Danton Goei | M | - |
Georgetown University
| 4 jaar |
Bradley Tirpak | M | 54 |
Georgetown University
| 2 jaar |
Steven Gasul Simon | M | - |
Georgetown University
| 3 jaar |
Enrique Quiason | M | 63 |
Georgetown University
| 3 jaar |
Nicole Inui | F | - |
Georgetown University
| 4 jaar |
Eric Shi | M | 63 |
Georgetown University
| 1 jaar |
David S. Lippes | M | - |
Georgetown University
| 3 jaar |
Elizabeth M. Costa | F | - |
Georgetown University
| 4 jaar |
Derek M. Stoldt | M | - |
Georgetown University
| 3 jaar |
Charles Benziger | M | - |
Georgetown University
| 4 jaar |
Magzhan Muratovich Auezov | M | 48 |
Georgetown University
| 4 jaar |
Vani Chetty | F | 53 |
Georgetown University
| 3 jaar |
Sanda Simanavicius | F | - |
Georgetown University
| 4 jaar |
Rupe Anthony Robert | M | - |
Georgetown University
| 4 jaar |
Peggy H. Roberts | F | - |
Georgetown University
| 4 jaar |
Brian M. Schafer | M | - |
Georgetown University
| 4 jaar |
Alberto Garcia-Tunon | M | - |
Georgetown University
| 4 jaar |
Tiffany F. Kosch | F | 54 |
Georgetown University
| 4 jaar |
Timothy J. Shea | M | - |
Georgetown University
| 3 jaar |
Charles Brendan Johnson | M | - |
Georgetown University
| 3 jaar |
Michael K. Kim | M | - |
Georgetown University
| 2 jaar |
John E. Bowman | M | - |
Georgetown University
| 4 jaar |
Bewley Stephen | M | - |
Georgetown University
| 4 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigde Staten | 94 | 94.00% |
Hongkong | 6 | 6.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties